ILYA Pharma

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients

[ILYA Pharma @ilyapharma]

Now published the non-clinical package for the #ILP100 #oral being developed as first-line-treatment for ICI-induced colitis.

Read how the the bacteria interacts with the immune system at Peyers Patches and delivers the #CXCL12 here: https://t.co/WH2RnD9ORw

[AdTherapiesCongress @AdTherapiesConf]

Don't miss out on our session about 'regulatory for academic and early-companies' led by speakers from @sparktx, @MedNous, @US_FDA, and @ilyapharma!

This is a unique opportunity you don't want to miss! Join us today 👉 https://t.co/nmjAzy9bnC

[ILYA Pharma @ilyapharma]

@ChristianGoritz Great example of curiosity and dedication! Well deserve Christian and Eduardo😀

[Farmaceutiska fakulteten @FFakulteten]

The Faculty Day 2024 with highly appreciated lectures by Evelina Vågesjö of @ilyapharma and Sebastian Ueckert of Ribocure Pharmaceuticals, crowned by a magical show by Johan Ståhl at the evening mingle at Pharmen turned out a well attended success 👉 https://t.co/IHqWFTHJQ3

[ILYA Pharma @ilyapharma]

Podcast (In Swedish) released today where our CEO gives an update on the companys products, clinical developments and the companys future.

Thanks to our backers Polynom Invest😀
https://t.co/D6T5ndv3nI

#value #innovation #clinicaltrials

[ILYA Pharma @ilyapharma]

Happy to participate and contribute to #ECMC2023 September 17-21 in Leuven BE

Thanks to Professor Paul Proost and team at the #REGAInstitute for leading the way for chemokines and their application😀

Full program: https://t.co/wA6H2EjOBx

#ILP100 #topical #oral #clinicaltrials

[ILYA Pharma @ilyapharma]

Dr Andreas Fasth will present the planned SITU-SURGERY trial at the US Military partnering conference MHSRS in Kissimmee, FL on August 16
#ILP100 #SITUSURGERY #ATMP #topical #surgery #obesit #diabetes #pre-diabetes #SITUSURGERY #topical #surgery #obesit #diabetes #prediabetes

[ILYA Pharma @ilyapharma]

First clinical trial with #ILP100 #emilimogene #sigulactibac published!

#RCT #Lancet #Discovery #eclinicalmedicine #ATMP #CGT #synbio #innovation #H2020 #EICAccelerator

[ILYA Pharma @ilyapharma]

Thanks @DHammarlof and also thanks to the whole #NMMP2023 for a great and inspiring event - there is great science, great scientists and with great networks and openness for collaborations innovations prosper!

[Disa Hammarlöf @DHammarlof]

’Bucket list’ talk for me now at #NMMP2023: Evelina Vågesjö, CEO & cofounder @ilyapharma @UU_University on what’s in the pipeline, from #fundamental #science to #drugdiscovery #innovation #patents, also sharing tips&tricks: #integrity #team #documentation #Methodology #validation

[ILYA Pharma @ilyapharma]

This week Prof. Mia Phillipson is giving a presentation at the Broad Institute of MIT and Harvard about her research in gut barrier, immune cell functions and how they can be targeted at PPs and giving an update on Ilya Pharmas #ILP100 #Oral program.
https://t.co/yWGgTeMESg

[ILYA Pharma @ilyapharma]

Happy to present at the International Society for Cell- and Gene Therapy 2023, Annual Meeting Paris March 6

The Value of early Regulatory Interactions with Authorities for emilimogene sigulactibac (INN) - a new modality in gene therapy, presented by Margareth Jorvid

#ILP100

[ILYA Pharma @ilyapharma]

Present at the 2023 J.P. Morgan Healthcare Conference week😎 . Pls reach out for meetings w the team🙏🏼

#synteticbiology #CGT #ATMP #innovation #diabetes #obesity #colitis #fibrosis #ICI #oncology #ILP100 #topical #oral #value #clinicaltrials #scaleup #nordicmade

[Krzysztof Potempa @BRAINCURES]

Evelina Vågesjö, co-founder and CEO of Swedish biotech startup @ilyapharma, believes we need some form of collaboration on how to view genetically modified organisms for pharmaceutical development @j_ivories @Labiotech_eu
https://t.co/dCqdYN5Fyw
#synbio
https://t.co/HhlHBwWor0

[PharmaVoice @PharmaVoice]

As co-founder and CEO @Ilyapharma, Evelina Vågesjö is driven by the relentless determination to bring scientific discoveries into the real world for patients.

That's why she's working on a new modality to speed wound healing.
https://t.co/fKFmJpxXrz

[ILYA Pharma @ilyapharma]

Next week, our CEO Evelina Vågesjö will meet, engage and present our latest developments at #Biofuture - Reimagine the future of therapeutics in #NYC at the #Lotte 8-9 November.

Link to conference: https://t.co/gymBgAfA7y

[ILYA Pharma @ilyapharma]

Well done Andreas Fasth, Head of Clinical Developments and Medical Affairs, representing our science and making new friends at the US Military Health System Research Symposia #MHSRS in FL!

https://t.co/OQ4qPnEjUo
#Science #innovation #ILP100 #clinicaltrials

[ILYA Pharma @ilyapharma]

#Beyondbiotech August episode 11 - hear our CEO Evelina Vågesjö and CFO Oskar Lund give an update - at 29:50 to 43:00.

https://t.co/4tZgkyagLu

#pharma #synbio #clinicaltrials #ICI #colitis #skin #wounds #FDA #IND #compositeendpoint #ILP100

[ILYA Pharma @ilyapharma]

Four new patents in major markets💰🧠⚗️💊🔬🧬🧫🧪🩸🩹
https://t.co/1TKbonuPh3

[ILYA Pharma @ilyapharma]

We say most #welcome to a new company in the dynamic #synbio space - great highlight @FinancialTimes💰

We are using lactobacillus to deliver therapeutic proteins, #ILP100 is our lead candidate currently developed in two formulations #topical and #oral.

https://t.co/PqN8nt3p5C

[Advances in Skin & Wound Care @aswcjournal]

Read this month’s CME article for an in-depth discussion on diagnosing and treating different types of breast ulcers: https://t.co/sWqFBj8zR3

#CME #postoperative #BreastNeoplasm #MondorDisease #panniculitis #HidradenitisSuppurativa #intertrigo